GEP201706747B - Pharmaceutical composition for reducing the trimethylamine n-oxide level
- Google Patents
Pharmaceutical composition for reducing the trimethylamine n-oxide level
Info
Publication number
GEP201706747B
GEP201706747BGEAP201313706AGEAP2013013706AGEP201706747BGE P201706747 BGEP201706747 BGE P201706747BGE AP201313706 AGEAP201313706 AGE AP201313706AGE AP2013013706 AGEAP2013013706 AGE AP2013013706AGE P201706747 BGEP201706747 BGE P201706747B
Authority
GE
Georgia
Prior art keywords
trimethylamine
reducing
pharmaceutical composition
oxide level
oxide
Prior art date
Application number
GEAP201313706A
Inventor
Ivars Kalvins
Maija Dambrova
Edgars Liepins
Elina Makarova
Osvalds Pugovics
Solveiga Grinberga
Eduards Sevostjanovs
Original Assignee
Latvian Inst Organic Synthesis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvian Inst Organic SynthesisfiledCriticalLatvian Inst Organic Synthesis
Priority to GEAP201313706ApriorityCriticalpatent/GEP201706747B/en
Publication of GEP201706747BpublicationCriticalpatent/GEP201706747B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Present invention relates to usage of pharmaceutical compositions containing 3-(2,2,2-trimethylhydrazinium)propionate, pharmaceutically acceptable salt therefor decreasing trimethylamine N-oxide level in human organism.
GEAP201313706A2013-10-242013-10-24Pharmaceutical composition for reducing the trimethylamine n-oxide level
GEP201706747B
(en)